Promoting full-length protein production is a requisite step to address some of the remaining unmet medical needs for those with Cystic Fibrosis (CF) nonsense alleles. ELX-02 promotes read-through of mRNA transcripts bearing nonsense mutations, including the most common CF nonsense allele G542X, in several different preclinical models including human bronchial epithelial cells. Here we evaluate ELX-02 mediated read-through using the CFTR-dependent Forskolin-induced swelling (FIS) assay across a selection of G542X genotype patient-derived organoids (PDOs).

Discover more from HUB

Explore our organoid screening platform 

discover more

Discover other publications on patient-derived organoids.

browse now